DE602004026437D1 - Pharmazeutische zusammensetzung auf basis von ketorolac oder einem seiner pharmazeutisch annehmbaren salze und verwendung von ketorolac oder seinen salzen in pharmazeutischen zusammensetzungen - Google Patents
Pharmazeutische zusammensetzung auf basis von ketorolac oder einem seiner pharmazeutisch annehmbaren salze und verwendung von ketorolac oder seinen salzen in pharmazeutischen zusammensetzungenInfo
- Publication number
- DE602004026437D1 DE602004026437D1 DE602004026437T DE602004026437T DE602004026437D1 DE 602004026437 D1 DE602004026437 D1 DE 602004026437D1 DE 602004026437 T DE602004026437 T DE 602004026437T DE 602004026437 T DE602004026437 T DE 602004026437T DE 602004026437 D1 DE602004026437 D1 DE 602004026437D1
- Authority
- DE
- Germany
- Prior art keywords
- ketorolac
- salts
- pharmaceutical
- pharmaceutical composition
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- OZWKMVRBQXNZKK-UHFFFAOYSA-N ketorolac Chemical compound OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 OZWKMVRBQXNZKK-UHFFFAOYSA-N 0.000 title abstract 6
- 229960004752 ketorolac Drugs 0.000 title abstract 6
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 5
- 150000003839 salts Chemical class 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 239000001913 cellulose Substances 0.000 abstract 1
- 229920002678 cellulose Polymers 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 239000000600 sorbitol Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI0302736A BRPI0302736B8 (pt) | 2003-06-02 | 2003-06-02 | composição farmacêutica a base de cetorolaco ou de um de seus sais farmaceuticamente aceitáveis para uso sublingual |
| PCT/BR2004/000077 WO2004105678A2 (en) | 2003-06-02 | 2004-05-26 | Pharmaceutical composition based on ketorolac or one of its salts pharmaceutically acceptable and use of ketorolac or its salts in pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602004026437D1 true DE602004026437D1 (de) | 2010-05-20 |
Family
ID=36584875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602004026437T Expired - Lifetime DE602004026437D1 (de) | 2003-06-02 | 2004-05-26 | Pharmazeutische zusammensetzung auf basis von ketorolac oder einem seiner pharmazeutisch annehmbaren salze und verwendung von ketorolac oder seinen salzen in pharmazeutischen zusammensetzungen |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7879901B2 (de) |
| EP (1) | EP1633342B1 (de) |
| AT (1) | ATE463243T1 (de) |
| BR (1) | BRPI0302736B8 (de) |
| DE (1) | DE602004026437D1 (de) |
| ES (1) | ES2344984T3 (de) |
| WO (1) | WO2004105678A2 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2007003948A (es) * | 2007-04-02 | 2009-02-25 | World Trade Imp Export Wtie Ag | Composicion farmaceutica en forma de tableta sublingual que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor. |
| WO2008150887A1 (en) * | 2007-05-29 | 2008-12-11 | Livescribe, Inc. | Self-addressing paper |
| MX2013008993A (es) | 2013-08-02 | 2014-03-24 | Raam De Sahuayo S A De C V Lab | Sistema de liberacion modificada en tres fases de un antiinflamatorio no esteroide. |
| WO2018197932A1 (en) * | 2017-04-27 | 2018-11-01 | Dr. Reddy's Laboratories Ltd. | Pharmaceutical compositions of ketorolac |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4089969A (en) | 1976-07-14 | 1978-05-16 | Syntex (U.S.A.) Inc. | 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof |
| US5288497A (en) | 1985-05-01 | 1994-02-22 | The University Of Utah | Compositions of oral dissolvable medicaments |
| ES2086536T3 (es) | 1990-03-16 | 1996-07-01 | Procter & Gamble | Uso de ketorolaco para el tratamiento de la enfermedad periodontal. |
| AU653026B2 (en) * | 1991-06-07 | 1994-09-15 | Teikoku Seiyaku Kabushiki Kaisha | Physiologically active polypeptide-containing pharmaceutical composition |
| DE69333009T2 (de) | 1992-11-09 | 2003-12-04 | Neurogesx Inc | Transdermale verabreichung von ketorolac |
| US5626838A (en) | 1995-03-13 | 1997-05-06 | The Procter & Gamble Company | Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx |
| US5976566A (en) | 1997-08-29 | 1999-11-02 | Macrochem Corporation | Non-steroidal antiinflammtory drug formulations for topical application to the skin |
| US6090368A (en) | 1998-03-03 | 2000-07-18 | The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations | Pharmaceutical compositions for intranasal spray administration of ketorolac tromethamine |
| MXPA03001407A (es) * | 2000-08-18 | 2003-06-06 | Pharmacia Corp | Formulacion oral de desintegracion rapida de un inhibidor de ciclooxigenasa-2. |
| US6685951B2 (en) | 2001-07-05 | 2004-02-03 | R. T. Alamo Ventures I, Inc. | Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine |
| ES2271542T3 (es) * | 2002-02-07 | 2007-04-16 | Pharmacia Corporation | Forma de dosificacion farmaceutica para administracion por la mucosa. |
-
2003
- 2003-06-02 BR BRPI0302736A patent/BRPI0302736B8/pt not_active IP Right Cessation
-
2004
- 2004-05-26 EP EP04734795A patent/EP1633342B1/de not_active Expired - Lifetime
- 2004-05-26 ES ES04734795T patent/ES2344984T3/es not_active Expired - Lifetime
- 2004-05-26 US US10/559,252 patent/US7879901B2/en not_active Expired - Fee Related
- 2004-05-26 AT AT04734795T patent/ATE463243T1/de not_active IP Right Cessation
- 2004-05-26 DE DE602004026437T patent/DE602004026437D1/de not_active Expired - Lifetime
- 2004-05-26 WO PCT/BR2004/000077 patent/WO2004105678A2/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004105678A2 (en) | 2004-12-09 |
| EP1633342A4 (de) | 2008-03-05 |
| EP1633342A2 (de) | 2006-03-15 |
| ES2344984T3 (es) | 2010-09-13 |
| ATE463243T1 (de) | 2010-04-15 |
| US7879901B2 (en) | 2011-02-01 |
| US20060128782A1 (en) | 2006-06-15 |
| BRPI0302736B8 (pt) | 2021-05-25 |
| BR0302736B1 (pt) | 2014-07-29 |
| BR0302736A (pt) | 2005-05-10 |
| WO2004105678A3 (en) | 2005-04-21 |
| EP1633342B1 (de) | 2010-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200500891A1 (ru) | Фармацевтические композиции, содержащие щелочные или соответственно кислые лекарственные соединения, поверхностно-активное вещество и физиологически приемлемую водорастворимую кислоту или соответственно основание | |
| CO5251419A1 (es) | Composiciones nanoparticuladas de eplerenona | |
| EA200400664A1 (ru) | Фармацевтические композиции, включающие метформин и глибенкламид, применяемые для лечения сахарного диабета типа ii | |
| TW200621257A (en) | Pyrimidine derivative fused with nonaromatic ring | |
| IL147852A0 (en) | Chemokine receptor antagonists and pharmaceutical compositions containing the same | |
| AP1849A (en) | Dosage regimen and pharmaceutical composition for emergency contraception | |
| EA200000487A1 (ru) | Композиция пролонгированного высвобождения | |
| RU2012109392A (ru) | Фармацевтическая композиция для ослабления боли | |
| WO2007064620A3 (en) | Compositions comprising a combination of ccr5 and cxcr4 antagonists | |
| ATE463243T1 (de) | Pharmazeutische zusammensetzung auf basis von ketorolac oder einem seiner pharmazeutisch annehmbaren salze und verwendung von ketorolac oder seinen salzen in pharmazeutischen zusammensetzungen | |
| DE60301351D1 (de) | Pharmazeutische Desmopressin-Zubereitung als feste Darreichungsform und Methode zu ihrer Herstellung | |
| ES2083708T3 (es) | Nuevas piperazinilalcoil-3 dihidro-2,3,4h-benzoxazina-1,3 onas-4 sustituidas, su preparacion y su aplicacion en terapeutica. | |
| UA92134C2 (ru) | Соединение, обладающее анти-вгс действием, и фармацевтическая композиция, содержащая его | |
| HUP0103071A2 (hu) | Citalopramot tartalmazó gyógyászati készítmény | |
| KR890006235A (ko) | 피페리디노알칸올용 제약 조성물 | |
| BR0207297A (pt) | Composição farmacêutica em forma sólida e método de preparar uma forma de dosagem sólida de um ingrediente farmaceuticamente ativo | |
| EA200100869A1 (ru) | Кристаллическая форма эплеренона | |
| KR900011461A (ko) | 트립스타틴을 유효성분으로 하는 치료제 | |
| HRP20050025A2 (en) | Pegylated t1249 polypeptide | |
| WO2005014007B1 (es) | Compuestos para el tratamiento de enfermedades desmielinizantes y autoinmunes | |
| MXPA04005033A (es) | Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes. | |
| YU81101A (sh) | Polimorfni oblici kristalnog citrata azabiciklo (2,2,2) oktan-3-amina i njihovih farmaceutskih kompozicija | |
| US3567828A (en) | Organic compounds | |
| BR0113140A (pt) | Antagonistas de receptor de ccr1 não peptìdico em combinação com ciclosporina a para o tratamento da rejeição de transplante de coração | |
| HUP0302620A2 (hu) | Új cukorbetegség-ellenes kombinációs gyógyszerkészítmények és eljárás ezek előállítására |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |